Jim Tananbaum's Insider Trades & SAST Disclosures
Jim Tananbaum's most recent trade in Kinnate Biopharma Inc was a trade of 1,550,956 Common Stock done at an average price of $2.8 . Disclosure was reported to the exchange on May 8, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jim Tananbaum.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kinnate Biopharma Inc | Jim Tananbaum | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.80 per share. | 08 May 2023 | 1,550,956 | 3,525,957 | - | 2.8 | 4,342,677 | Common Stock |
| Kinnate Biopharma Inc | Jim Tananbaum | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.80 per share. | 08 May 2023 | 229,044 | 520,711 | - | 2.8 | 641,323 | Common Stock |
| Kinnate Biopharma Inc | Jim Tananbaum | Director, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 17 Feb 2023 | 1,100,000 | 1,975,001 | - | - | Common Stock | |
| Kinnate Biopharma Inc | Jim Tananbaum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 20,250 | 20,250 | - | - | Stock Option (right to buy) | |
| Disc Medicine Inc | Jim Tananbaum | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2021 | 17,245 | 17,245 | - | - | Stock Option (Right to Buy) | |
| Disc Medicine Inc | Jim Tananbaum | Director | 05 Feb 2021 | 2,928,750 | 2,928,750 | - | 0 | Common Stock | ||
| Disc Medicine Inc | Jim Tananbaum | Director | 05 Feb 2021 | 2,928,750 | 0 | - | - | Common Stock | ||
| Disc Medicine Inc | Jim Tananbaum | Director | Grant, award, or other acquisition of securities at price $ 10.00 per share. | 05 Feb 2021 | 1,500,000 | 1,500,000 | - | 10 | 15,000,000 | Common Stock |
| Kinnate Biopharma Inc | Jim Tananbaum | Director, Ten Percent Owner | 07 Dec 2020 | 9,171,643 | 9,671,643 | - | 0 | Common Stock | ||
| Kinnate Biopharma Inc | Jim Tananbaum | Director, Ten Percent Owner | 07 Dec 2020 | 6,347,893 | 0 | - | - | Series A Preferred Stock | ||
| Kinnate Biopharma Inc | Jim Tananbaum | Director, Ten Percent Owner | 07 Dec 2020 | 2,666,002 | 0 | - | - | Series B Preferred Stock | ||
| Kinnate Biopharma Inc | Jim Tananbaum | Director, Ten Percent Owner | 07 Dec 2020 | 500,001 | 875,001 | - | 0 | Common Stock | ||
| Kinnate Biopharma Inc | Jim Tananbaum | Director, Ten Percent Owner | 07 Dec 2020 | 298,465 | 0 | - | - | Series A Preferred Stock | ||
| Kinnate Biopharma Inc | Jim Tananbaum | Director, Ten Percent Owner | 07 Dec 2020 | 166,667 | 291,667 | - | 0 | Common Stock | ||
| Kinnate Biopharma Inc | Jim Tananbaum | Director, Ten Percent Owner | 07 Dec 2020 | 157,222 | 0 | - | - | Series C Preferred Stock | ||
| Kinnate Biopharma Inc | Jim Tananbaum | Director, Ten Percent Owner | 07 Dec 2020 | 145,128 | 0 | - | - | Series C Preferred Stock | ||
| Kinnate Biopharma Inc | Jim Tananbaum | Director, Ten Percent Owner | 07 Dec 2020 | 99,488 | 0 | - | - | Series A Preferred Stock | ||
| Kinnate Biopharma Inc | Jim Tananbaum | Director, Ten Percent Owner | 07 Dec 2020 | 55,922 | 0 | - | - | Series B Preferred Stock | ||
| Kinnate Biopharma Inc | Jim Tananbaum | Director, Ten Percent Owner | 07 Dec 2020 | 48,376 | 0 | - | - | Series C Preferred Stock | ||
| Kinnate Biopharma Inc | Jim Tananbaum | Director, Ten Percent Owner | 07 Dec 2020 | 18,641 | 0 | - | - | Series B Preferred Stock | ||
| Kinnate Biopharma Inc | Jim Tananbaum | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 03 Dec 2020 | 500,000 | 500,000 | - | 20 | 10,000,000 | Common Stock |
| Kinnate Biopharma Inc | Jim Tananbaum | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 03 Dec 2020 | 375,000 | 375,000 | - | 20 | 7,500,000 | Common Stock |
| Kinnate Biopharma Inc | Jim Tananbaum | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 20.00 per share. | 03 Dec 2020 | 125,000 | 125,000 | - | 20 | 2,500,000 | Common Stock |
| Kinnate Biopharma Inc | Jim Tananbaum | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2020 | 40,501 | 40,501 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges